GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (XSWX:ROG) » Definitions » Dividends per Share

Roche Holding AG (XSWX:ROG) Dividends per Share

: CHF9.50 (TTM As of Dec. 2023)
View and export this data going back to 2001. Start your Free Trial

Roche Holding AG's dividends per share for the six months ended in Dec. 2023 was CHF0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF9.50. Its Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, Roche Holding AG's Dividend Yield % is 4.36%.

Good Sign:

Roche Holding AG stock dividend yield is close to 10-year high.

During the past 12 months, Roche Holding AG's average Dividends Per Share Growth Rate was 2.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 1.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 2.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Roche Holding AG was 32.00% per year. The lowest was 1.20% per year. And the median was 10.80% per year.

For more information regarding to dividend, please check our Dividend Page.


Roche Holding AG Dividends per Share Historical Data

The historical data trend for Roche Holding AG's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividends per Share
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.70 9.00 9.10 9.30 9.50

Roche Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Dividends per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 9.30 - 9.50 -

Competitive Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG Dividend Yield % Distribution

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Dividend Yield % falls into.



Roche Holding AG Dividends per Share Calculation

Dividends paid to per common share.


Roche Holding AG  (XSWX:ROG) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Roche Holding AG's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 8.47
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Roche Holding AG was 0.59. The lowest was 0.43. And the median was 0.49.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Roche Holding AG Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CHF 9.6002024-03-142024-03-152024-03-18Cash DividendannuallyCHF:CHF 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.


Roche Holding AG's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=9.6/222.10
=4.32 %

Current Share Price is CHF222.10.
Roche Holding AG's Dividends per Share for the trailing twelve months (TTM) ended in Today is CHF9.6.

During the past 13 years, the highest Dividend Yield of Roche Holding AG was 4.36%. The lowest was 2.28%. And the median was 2.99%.

Good Sign:

Roche Holding AG stock dividend yield is close to 10-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG Dividends per Share Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Roche Holding AG (XSWX:ROG) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.